IIOT-OXYS, Inc. (ITOX)
Cambridge, MA, US
IIOT-OXYS, Inc. identifies, develops, and markets engineered products, software, and services for industrial internet applications. It develops hardware, software, and algorithms that monitor, measure, and predict conditions for energy, structural, agricultural and medical applications. The company also offers Oxys solutions; and structural health monitoring system, a solar powered bridge monitoring system for manufacturing, biotech, pharmaceutical, medical device, and infrastructure markets. IIOT-OXYS, Inc. is based in Cambridge, Massachusetts.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -14.29% | +0.00% | -33.33% | -44.44% | -7.69% | -14.29% | -36.84% | -68.42% | -95.92% | -99.80% | -99.76% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Software - Application: +13.0%-100.0%
-
EPS growth Software - Application: +28.6%-85.7% Q1'26: -133.3% (vs Q1'25)
-
FCF margin FCF growth · Software - Application: +45.3%—
-
EBIT margin Software - Application: +9.4%—
-
ROIC Software - Application: +7.5%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Software - Application: +0.0%+3.6% Q1'26: +5.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Software - Application: -1.16×-0.04×
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-02 | Schissler Matthew Lawrence | Director | — | — | Series D Preferred Stock | 525,000,000 | 0.00 | — | 0 | I | ↗ |
| 2025-12-02 | Hajee Sarfraz | Director | — | — | Series D Preferred Stock | 525,000,000 | 0.00 | — | 0 | I | ↗ |
| 2025-12-02 | Grober Mark | Director | — | — | Series D Preferred Stock | 525,000,000 | 0.00 | — | 0 | I | ↗ |
| 2025-11-05 | Schissler Matthew Lawrence | Director | — | — | Series A Preferred Stock | 10,000 | 0.00 | — | 0 | I | ↗ |
| 2025-11-05 | Mitta Vidhyadhar | Director | J-Other | A | Series E Convertible Preferred Stock | 180 | 0.00 | 0.09 | 433,736,843 | D | ↗ |
| 2025-11-05 | McNemar Karen | Other | J-Other | A | Series E Convertible Preferred Stock | 269 | 0.00 | 0.13 | 654,404,500 | D | ↗ |
| 2025-11-05 | Hajee Sarfraz | Director | — | — | Series A Preferred Stock | 10,000 | 0.00 | — | 0 | I | ↗ |
| 2025-11-05 | Grober Mark | Director | — | — | Series A Preferred Stock | 10,000 | 0.00 | — | 0 | I | ↗ |
| 2025-11-05 | Emmons Clifford L | Director / Officer | J-Other | D | Series A Super-Voting Preferred Stock | 7,800 | 0.00 | — | 9,280,000 | D | ↗ |
| 2024-10-04 | Schissler Matthew Lawrence | Director | — | — | Series B Preferred Stock | 1,166,000,000 | 0.00 | — | 0 | I | ↗ |
| 2024-10-04 | Hajee Sarfraz | Director | — | — | Series B Preferred Stock | 1,166,000,000 | 0.00 | — | 0 | I | ↗ |
| 2024-10-04 | Grober Mark | Director | — | — | Series B Preferred Stock | 1,166,000,000 | 0.00 | — | 0 | I | ↗ |
| 2024-04-01 | McNemar Karen | Officer | A-Award | A | Common Stock | 2,500,000 | 0.00 | — | 5,804,500 | — | ↗ |
| 2024-04-01 | Emmons Clifford L | Director / Officer | A-Award | A | Common Stock | 2,500,000 | 0.00 | — | 6,280,500 | — | ↗ |
| 2023-04-01 | McNemar Karen | Officer | A-Award | A | Common Stock | 1,500,000 | 0.00 | — | 3,304,500 | — | ↗ |
| 2023-04-01 | Emmons Clifford L | Director / Officer / 10% Owner | A-Award | A | Common Stock | 1,500,000 | 0.00 | — | 3,780,000 | — | ↗ |
| 2021-04-01 | Seshagiri Chandran V | Officer | — | D | Common Stock | 0 | 0.00 | — | 50,000 | — | ↗ |
| 2020-11-09 | Mitta Vidhyadhar | Director / 10% Owner | U-Tender | A | Series A Supervoting Preferred Stock | 12,000 | 100.00 | 1.20M | 172,325,533 | — | ↗ |
| 2020-11-09 | McNemar Karen | Officer | U-Tender | A | Series A Supervoting Preferred Stock | 6,045 | 100.00 | 604.5K | 1,209,000 | — | ↗ |
| 2020-11-09 | Emmons Clifford L | Director / Officer / 10% Owner | U-Tender | D | Common Stock | 780,000 | 0.00 | — | 2,280,000 | — | ↗ |
| 2020-10-01 | McNemar Karen | Officer | A-Award | A | Common Stock | 800,000 | 0.00 | — | 1,209,000 | — | ↗ |
| 2020-07-29 | Schissler Matthew Lawrence | Director | — | — | Convertible Note | 23,158,450 | 0.00 | 13.9K | 0 | I | ↗ |
| 2020-07-29 | Hajee Sarfraz | Director | — | — | Convertible Note | 23,158,450 | 0.00 | 13.9K | 0 | I | ↗ |
| 2020-07-29 | Grober Mark | Director | — | — | Convertible Note | 23,158,450 | 0.00 | 13.9K | 0 | I | ↗ |
| 2019-10-16 | Mitta Vidhyadhar | Director | P-Purchase | A | Warrants | 156,250 | 0.12 | 18.8K | 2,343,750 | — | ↗ |
| 2019-10-01 | McNemar Karen | Officer | A-Award | A | Common Stock | 409,000 | 0.00 | — | 409,000 | — | ↗ |
| 2019-09-06 | Mitta Vidhyadhar | Director | P-Purchase | A | Warrants | 156,250 | 0.12 | 18.8K | 1,875,000 | — | ↗ |
| 2019-08-02 | Mitta Vidhyadhar | Director | P-Purchase | A | Warrants | 468,750 | 0.12 | 56.3K | 1,406,250 | — | ↗ |
| 2019-04-22 | Coufal Antony | Officer | C-Conversion | A | Common Stock | 454,546 | 0.10 | 45.0K | 2,254,546 | — | ↗ |
| 2019-03-11 | Emmons Clifford L | Director / Officer | A-Award | A | Common Stock | 3,060,000 | 0.00 | — | 3,060,000 | — | ↗ |
| 2019-03-11 | Coufal Antony | Officer | — | D | Common Stock | 0 | 0.00 | — | 1,800,000 | — | ↗ |
| 2019-01-22 | Emmons Clifford L | Director / Officer | P-Purchase | A | 5% Secured Convertible Note | 84,615 | 0.65 | 55.0K | 84,615 | — | ↗ |
| 2018-09-28 | Coufal Antony | Officer | — | D | Common Stock | 0 | 0.00 | — | 1,200,000 | — | ↗ |
| 2018-09-25 | McNemar Karen | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2018-06-04 | Emmons Clifford L | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2018-01-11 | Phillips Patrick | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 1,500,000 | — | ↗ |
| 2017-07-28 | Mitta Vidhyadhar | Director | — | D | Common Stock | 0 | 0.00 | — | 1,736,843 | — | ↗ |
| 2017-07-28 | Hanumara Nevan C | Director | — | D | Common Stock | 0 | 0.00 | — | 3,000,000 | — | ↗ |
| 2017-07-28 | DiBiase Giro | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 3,000,000 | — | ↗ |
| 2004-01-01 | GENERELLI DANIEL | Director / Officer | — | D | common shares | 0 | 0.00 | — | 40,000 | — | ↗ |
| 2004-01-01 | CATIZONE PASQUALE | 10% Owner | — | D | common shares | 0 | 0.00 | — | 4,887,500 | — | ↗ |
| 2004-01-01 | CATIZONE CARMINE | Director / Officer / 10% Owner | — | I | common shares | 0 | 0.00 | — | 80,600 | — | ↗ |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Clifford L. Emmons | CEO, President & Director | 91.7K | male |
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ITOX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
